Historical record - last NADAC publication: 6/22/2016
Product Information
HYDROMORPHONE 3 MG SUPPOS is a generic product labeled by Padagis US LLC, priced at $9.5820 per EA under NDC 00574722406. Its NADAC has been published 156 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the HYDROMORPHONE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/1
Manufacturer
Padagis US LLCNDC
00574722406
Classification
Generic
Dosage Form
SUPPOSITORY
Route
RECTAL
Last Updated
6/22/2016
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Unapproved
On Market Since
1/31/1996
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE 3 MG SUPPOS has been published 156 times since Nov 28, 2013, and over the history we have for it it has declined 6.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5820 per EA |
|---|---|
| All-time high | $10.2867 (Jul 16, 2014) |
| All-time low | $9.5820 (Jun 22, 2016) |
| Median price | $10.0807 |
| Average price | $9.9193 |
| Largest weekly change | -4.9% (Jun 22, 2016) |
| Weeks tracked | 156 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the HYDROMORPHONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of HYDROMORPHONE 3 MG SUPPOS?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE 3 MG SUPPOS, manufactured by Padagis US LLC, is $9.5820 per EA (NDC 00574722406), effective Jul 12, 2017.
How has the price of HYDROMORPHONE 3 MG SUPPOS changed over time?
Over the history we have for it, the NADAC for HYDROMORPHONE 3 MG SUPPOS has declined 6.9%. It has been tracked across 156 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE 3 MG SUPPOS?
Since Nov 28, 2013, the NADAC for HYDROMORPHONE 3 MG SUPPOS has ranged from a low of $9.5820 (Jun 22, 2016) to a high of $10.2867 (Jul 16, 2014), with a median of $10.0807 per EA.
Are there cheaper alternatives to HYDROMORPHONE 3 MG SUPPOS?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of HYDROMORPHONE 3 MG SUPPOS, so no direct lower-cost alternative is listed.
Who manufactures HYDROMORPHONE 3 MG SUPPOS?
HYDROMORPHONE 3 MG SUPPOS (NDC 00574722406) is labeled by Padagis US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification